This elective will provide the student with the vocabulary necessary to understand and converse in the fields of medicine and health care in Spanish. It will focus on communication with a Spanish-speaking patient, as well as understanding cultural attitudes that may impact medical care. Listening, comprehension, and conversational skills will be stressed through dialogues and oral presentations. Students will develop cooperative learning and effective group dynamic skills necessary to accomplish course goals.

Prerequisites: Students must pass a prerequisite oral and written basic Spanish language evaluation prior to course registration. Two years of high school or college Spanish.

Credits: 2

This course provides an opportunity for PS-I, PS-II, and PS-III students to work with individual faculty mentors on projects of variable scope. Included activities could be library, laboratory, and/or survey-type research; assistance with syllabus development of future elective courses; or other activities agreed on between the student and mentor and approved by the appropriate department chair. A maximum of 4 credits of PPRAD or PSCID 1301 may be applied toward elective requirements for the Pharm.D. degree.

Credits: 1-3

Through hands-on involvement in a community service project and discussions with community leaders, the student will be better prepared to provide pharmaceutical care to a wider segment of the population. The issues addressed may include understanding the role of physical or mental disabilities, cultural sensitivity, language barriers, and alternative medicines in providing quality pharmaceutical care. This course includes development and implementation of a service project or participation in a project currently sponsored by the University. Permission of the instructor is required.

Credits: 1

The course emphasizes the skills and knowledge necessary to perform well in an acute care general medicine setting. The student will practice problem based learning in a team learning environment to devise appropriate therapeutic plans for disease states and clinical controversies commonly encountered in acute care practice. Instructors will utilize patient cases and interactive teaching methods.

Prerequisites: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1761 Pharmacotherapeutics VFor those entering the Doctor of Pharmacy Program in or after Summer 2021: Concurrent enrollment in PHIDD 1607 Integrated Sequence VII

Credits: 2

This course introduces students to issues associated with the provision of veterinary-focused pharmacy services. It provides a foundation for pharmacists interested in providing care for species other than humans. Pharmacology, unique physiologic and pharmacokinetic differences will be emphasized. Management and prevention of common diseases will be discussed.

Prerequisites: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1663 Pharmacotherapeutics IV, PPRAD 1681 Clinical Skills IFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PHIDD 1607 Integrated Sequence VII, PPRAD 1572 Clinical Skills Development II

Credits: 2

This course focuses on issues related to the treatment and care of pediatric patients. By following mock patients from birth through their adolescence, the elective is designed to introduce the students to common illnesses, drug delivery systems used for pediatric patients, and current controversies in pediatric care. Students have the opportunity to select topics of intent that will be covered in a portion of the course.

Prerequisites: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1532 Pharmacotherapeutics I, PPRAD 1661 Pharmacotherapeutics II, PRAD 1662 Pharmacotherapeutics III, PPRAD 1663 Pharmacotherapeutics IV.For those entering the Doctor of Pharmacy Program in or after Summer 2021: PHIDD 1502 Integrated Sequence II, PHIDD 1504 Integrated Sequence IV, Concurrent enrollment in PHIDD 1608 Integrated Sequence VIII.

Credits: 2

This elective concentrates on specific issues related to the optimal delivery of women's health care. Topics covered include sex related differences in treating women, wellness and prevention over the female life span, diseases uniquely affecting women, and pharmacotherapy and psychosocial aspects of women's health. Interactive lectures, group projects, and workshops will educate students about practical considerations in the health care of women. Community service will be encouraged.

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1661 Pharmacotherapeutics IIFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PHIDD 1504 Integrated Sequence IV, Concurrent enrollment in PHIDD 1506 Integrated Sequence VI

Credits: 2

This course will focus on advanced topics in the management of diabetes. Students will have the opportunity to practice application of the material through patient cases and hands-on experiences. Topics discussed will include a review of the classifications and diagnosis of diabetes, non-insulin and insulin therapies, cardiovascular outcomes trials and updates in primary literature, complications of diabetes, and a review of the devices available in the management of diabetes.

Prerequisites: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1662 Pharmacotherapeutics III, PPRAD 1681 Clinical SkillsFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PHIDD 1504 Integrated Sequence IV, PPRAD 1574 Clinical Skills Development IV

Credits: 2

This course expands students' knowledge and skills in area of infectious diseases and antimicrobial pharmacotherapy. A case-based approach will be utilized to foster an interactive learning experience. Students will build upon their current knowledge of infectious diseases and antimicrobials through case-related discussions and debates utilizing current guidelines, evidence-based primary literature, institutional policies and procedures, and expert opinions from guest facilitators.

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1663 Pharmacotherapeutics IVFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PHIDD 1607 Integrated Sequence VII, Concurrent enrollment in PHIDD 1608 Integrated Sequence VIII

Credits: 2

This course will enable students to gain the knowledge and skills necessary to provide comprehensive tobacco cessation counseling to patients who use tobacco. Topics of emphasis include epidemiology of tobacco use, principles of addition, methods of assisting patients with quitting, and available tobacco cessation products.

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1532 Pharmacotherapeutics IFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PPRAD 1573 Clinical Skills Development III

Credits: 1

Students enhance their patient care skills by examining the relationship between spirituality and health, learn the role of spirituality and religion in health care, and examine issues related to the interaction between spiritual outlook and compliance with medical treatment. Faculty and expert guest presenters lead discussions on how belief systems affect patients' perception of health, necessary spiritual considerations in patient care, therapeutic dilemmas produced by spiritual beliefs, and resources available to the health care team.

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1662 Pharmacotherapeutics IIIFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PHIDD 1504 Integrated Sequence IV

Credits: 2

In the critical care setting, pharmacists have a unique role on multidisciplinary medical teams through their expertise in pharmacotherapeutics, pharmacokinetics, and drug information. This course introduces students to select disease states encountered in the intensive care unit setting as well as current controversies regarding the clinical management of these patients. The therapeutic management of critically ill patients will be discussed using case study, interactive methods and lecture formats.

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: Concurrent enrollment in PPRAD 1761 Pharmacotherapeutics VFor those entering the Doctor of Pharmacy Program in or after Summer 2021: Concurrent enrollment in PHIDD 1609 Integrated Sequence IX

Credits: 2

Epidemiologic methods are increasingly used for questions not easily found answered through traditional clinical research pathways (e.g., randomized trials). Given health care's emphasis on evidence-based practice and population-based care, a firm understanding of epidemiologic principles is necessary for health care professionals. This course will introduce students to the population-oriented approach of epidemiology and its application to examining the use and effects of medications, as well as practice evaluation.

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1671 Evidence-Based Pharmacy PracticeFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PPRAD 1561 Pharmacy Practice Development and Evaluation I

Credits: 2

This course will explore anticoagulation in both the inpatient and outpatient settings through lecture, patient cases, and hands-on experiences. Students will develop a working knowledge and skill set required to provide pharmacy-managed anticoagulation services. Topics will include a review of currently available oral and parenteral anticoagulants as well as those in the pipeline, consideration in anticoagulation for special populations, and advanced therapeutic issues.

Prerequisites: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1662 Pharmacotherapeutics IIIFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PHIDD 1503 Integrated Sequence III

Credits: 2

This course reviews cardiovascular diseases for those students interested in cardiology. New topics (e.g. valvular disease) will be introduced, and previous topics discussed in required courses will be further augmented. Topics will focus on diagnostics and procedures, cardiovascular pharmacotherapy, and the role of the cardiology pharmacist. Active learning strategies and high-fidelity simulations are highly employed.

Prerequisites: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1662 Pharmacotherapeutics III,PPRAD 1681 Clinical Skills IFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PHIDD 1502 Integrated Sequence II, PHIDD 1503 Integrated Sequence III, PPRAD 1676 Clinical Skills Development VI

Credits: 2

The course reviews pharmacists' postgraduate training and educational opportunities with a focus on pharmacy residencies. Topics include, but are not limited to, the residency application process, types of available residencies and fellowships, and careers available after postgraduate training. Students will also be expected to create a high-quality curriculum vitae (CV) and letter of intent, which are standard components of most residency and fellowship application packages.

Credits: 1

This course will help students develop the skills necessary to analyze data, interpret the results of those analyses, and produce meaningful reports based on those analyses. Statistical techniques related to describing and visualizing data, comparing means, nonparametric tests, categorical data analysis, and regression modeling procedures will be presented in the course. Students will also be introduced to basic principles of data management, such as data file preparation, data manipulation, and recoding.

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1671 Evidence-Based Pharmacy PracticeFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PPRAD 1561 Pharmacy Practice Development and Evaluation I

Credits: 2

This course focuses on reviewing the clinical trial data that support therapeutic recommendations in ambulatory care. Students in this course critically evaluate clinical trials to reinforce skills in interpreting clinical trial data, practice applying the data to patient cases to support therapeutic recommendations, and identifying the rationale for current therapeutic guidelines.

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1662 Pharmacotherapeutics IIIFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PHIDD 1502 Integrated Sequence II, PHIDD 1503 Integrated Sequence III, PHIDD 1504 Integrated Sequence IV, PPRAD 1561 Pharmacy Practice Development and Evaluation I

Credits: 2

This course is focused on health promotion and disease prevention in ethnic minority groups. The goal of the course is to augment concepts taught in the curriculum with an emphasis on developing critical thinking skills in the setting of a health screening event in the community. Active learning techniques will be used during class time to improve students' knowledge, skills, and self-confidence when: (1) performing cardiometabolic screenings (e.g. cholesterol, blood glucose, and blood pressure) and (2) providing cross-cultural communication with patients' from different backgrounds.

Prerequisites: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1662 Pharmacotherapeutics III, PPRAD 1681 Clinical Skills IFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PHIDD 1504 Integrated Sequence IV, PHIDD 1551 Cultural Care and Public Health, PPRAD 1574 Clinical Skills Development IV

Credits: 1

This course is offered in conjunction with the annual AMCP Foundation Pharmacy and Therapeutics Competition. Using the AMCP formulary dossier format and a drug selected annually by AMCP, students prepare a drug monograph, develop an economic model and make a formulary recommendation for this designated drug for a simulated health plan. Students work in teams of four and present their recommendations to a judging panel. The top scoring team progress to the national competition.

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PPRAD 1671 Evidence-Based Pharmacy PracticeFor those entering the Doctor of Pharmacy Program in or after 2021: PPRAD 1561 Pharmacy Practice Development and Evaluation I

Credits: 2

This course provides an opportunity for PS-I, PS-II, and PS-III students to work with individual faculty mentors on projects of variable scope. Included activities could be library, laboratory, and/or survey-type research; assistance with syllabus development of future elective courses; or other activities agreed on between the student and mentor and approved by the appropriate department chair. A maximum of 4 credits of PPRAD or PSCID 1301 may be applied toward elective requirements for the Pharm.D. degree.

Credits: 1-3

Through hands-on involvement in a community service project and discussions with community leaders, the student will be better prepared to provide pharmaceutical care to a wider segment of the population. The issues addressed may include understanding the role of physical or mental disabilities, cultural sensitivity, language barriers, and alternative medicines in providing quality pharmaceutical care. This course includes development and implementation of a service project or participation in a project currently sponsored by the University. Permission of the instructor is required.

Credits: 1

This course provides an overview of issues related to biologics beyond those commonly prescribed. Focus will be on acid and cell-based therapies, biotechnology-derived vaccines, and proteins and monoclonal antibodies prescribed for less common disease states such as hemophilia. Background information related to production, storage and handling, and cost will be discussed as they relate to analytical techniques, patient education and counseling. Related topics including cloning, biopharming, genetic testing, and the Human Genome Project.

Prerequisites: BIOCD 1556 Biochemistry I, BIOCD 1557 Biochemistry II, PHIDD 1500 Integrated Sequence Foundations

Credits: 2

This course begins with a general overview of pharmacy throughout history, with special emphasis placed on Illinois pharmacy and pharmacy associations. The course will end with student-led presentations on individuals who can be considered heroes in the profession and who have been instrumental in the adaptation of our health care system to provide access to quality health care.

Credits: 2

This course provides an understanding as to what can happen to the environment (personal and wildlife) in the presence of chemicals associated with pharmaceuticals and personal care products (PPCPs). This course focuses on identification of PPCP sources and entry points, removal strategies, as well as documented and potential cause/effect relationships between specific chemical products/byproducts and wildlife species. When relevant, potential cause/effect relationships between these chemical entities and human systems (e.g. reproductive system) will be explored.

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PSCID 1621 Chemical Principles of Drug Action IFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PSCID 1523 Principles of Pharmaceutical Sciences

Credits: 1

This course provides an overview of the mechanisms and therapeutic uses of fat- and water-soluble vitamins, antioxidants, macro- and micro-minerals, and enteral nutritional support products. Topics include the use of anti-oxidants, multi-vitamin choices, potential toxicity and drug interactions, as well as nutritional support/supplement selection for infants and adults. The mechanism-based approach used in this module allows the student pharmacist to more easily identify, organize, and recommend various therapeutic agents for a wide variety of patients.

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PSCID 1622 Chemical Principles of Drug Action IIFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PHIDD 1502 Integrated Sequence II, Concurrent enrollment in PHIDD 1503 Integrated Sequence III

Credits: 2

This course develops knowledge and skills to facilitate the provision of inclusive, compassionate and holistic patient centered care to members of the Lesbian, Gay, Bisexual, Transgender, Queer, and Intersex (LGBTQI) community. Lecture topics include an introduction to LGBTQI terminology, culture and history, mental health and social service needs, and communication strategies. An emphasis on personal acknowledgement of knowledge/skills deficits may help to prevent health inequities for these populations in the future.

Credits: 2

This course will provide future healthcare professionals a basic understanding of the endocannabinoid system and the related pharmacokinetics/pharmacodynamics of medicinal cannabis. The use of medicinal cannabis in the management of pain, anxiety, insomnia, epilepsy, PTSD, and chemotherapy induced nausea and vomiting will be discussed. Historical, legal, and ethical issues will also be discussed. Patient education points associated with adverse effects, as well as potential drug-cannabis and nutrient-cannabis interactions will be emphasized.

Prerequisites: BIOCD 1556 Biochemistry I, BIOCD 1557 Biochemistry II, PHYSD 1524 Human Physiology I, PHYSD 1525 Human Physiology II

Credits: 1

This laboratory-based course will expose students to more advanced compounding techniques, formulation/dosage forms, and equipment. Lecture topics will include compounding safety, legislation, accreditation, marketing, and sources of compounding information and supplies

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: PSCID 1519 Dosage Form LaboratoryFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PSCID 1522 Dosage Forms Lab

Credits: 2

Botanical dietary supplements are used by at least 1/3 of the population as a component of complementary and integrative health with mainstream medical practice. Health care professionals should develop knowledge and skills necessary to aid patients in making rational decisions about their use. This elective focuses on the utility of drugs from natural sources in practice today, and surveys the products of plants and animals, and various complementary modalities of medicine that impact health.

Prerequisite: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: Concurrent enrollment or successful completion of PHARD 1651 Pharmacology IFor those entering the Doctor of Pharmacy Program in or after Summer 2021: BIOCD 1556 Biochemistry I, BIOCD 1557 Biochemistry II, Concurrent enrollment in PHIDD 1501 Integrated Sequence I and PHIDD 1502 Integrated Sequence II

Credits: 3

This advanced topics course will provide an in-depth knowledge on the clinical application of pharmacogenomics. Students will deepen their understanding of how genetic differences impact drug therapy and be able to interpret pharmacogenomic data and testing results. Students are expected to read assigned papers before class and participate in class activities and group discussions. Assessment will be based on student presentations, in class activities, case studies, short papers, and take home worksheets.

Prerequisites: For those who entered the Doctor of Pharmacy Program in Fall 2016 through Fall 2020: BIOCD 1554 Biochemistry I, BIOCD 1555 Biochemistry IIFor those entering the Doctor of Pharmacy Program in or after Summer 2021: PSCID 1523 Principles of Pharmaceutical Sciences

Credits: 2

The elective focuses on self-management during communication with patients diagnosed with disease states that limit their physical or mental abilities (e.g., stroke, paraplegia, quadriplegia, autism, physical deformity, learning disabilities). Implicit bias evaluation, as well as skill set development to facilitate self-management (compassion and empathy) will be emphasized. Expert panel presentations, mini-lectures and in-class activities. Student acknowledgement of personal deficits and bias may help to prevent healthcare inequities for these populations in the future.

Credits: 1